# Lilly reports third-quarter 2026 financial results, raises full-year guidance and highlights regulatory progress across the portfolio

> **Newsylist Open Intelligence Dossier** · First detected: 2026-10-29 12:29 UTC · Category: Business · Sources: 10 · Current Velocity: 11.86

## Intelligence Brief
"Lilly reports third-quarter 2026 financial results, raises full-year guidance and highlights regulatory progress across the portfolio" developed substantial multi-source reporting across the Business sector, tracked across 7 distinct newsrooms by Newsylist.


Key reporting was led by Crain's Chicago Business, Reuters, Yahoo Finance and WSJ. Coverage velocity and cross-outlet momentum were measured using Newsylist open coverage telemetry.


Synthesized from multi-source international reporting and live coverage telemetry under Newsylist open intelligence methodology.

## Verified Facts & Key Claims
### What drove coverage for Lilly reports third-quarter 2026 financial results, raises full-year guidan?
Coverage spiked when 7 independent newsrooms published 10 verified reports during this coverage cycle.

### How did Newsylist track this trend?
Newsylist monitored article arrival rates, source diversity, and cross-outlet validation in real time.

## Key People, Organizations & Locations
Lilly

## Multi-Source Evidence Table
| Source Outlet | Headline | Published (UTC) | Verification URL |
|---|---|---|---|
| Benzinga | AbbVie Raises 2026 Outlook, Boosts Dividend | 2026-10-30 11:51 | [Source Link](https://news.google.com/rss/articles/CBMioAFBVV95cUxQVE85RDRJRnpvSzlNLS1ta3hsaU5CTWctTXctb2V2dElmdkNVTjR1aDZDN3FEbWxKempONXU1dEItMC1hRV9CQ1B0WXczOTBDSXlNTWJ4dGJ1Q2VNWXpNckVIYnAxUnBGMkZPQ0lqenMyb3RUSUNMd3g4ZmYxVjltbnpGWlFlR2hCblBmVUFId1BRWngxNzB1R1hUM1BkWUow?oc=5) |
| TradingView | ABBV: Double-digit growth and raised guidance, led by immunology and neuroscience | 2026-10-30 11:51 | [Source Link](https://news.google.com/rss/articles/CBMi-gFBVV95cUxPRVRrMTI3Zk5JU0p1Z3B4VGl3cjc1OVZpcV9adXRNenVYU2F2QjFNYTNUZGN4T204dC02ZUt5Q2lQTGg0dFo2VTZONElRQ05qZkJadV9KV2gxWlFzcVhxblBDalYwQmlMNzdaQ0U4R1Y0aEtYendSbDRxS3ZhZ3lsckoyVEZNNnlCMWxJbHV1RFhHanF2NHQzb3pTZFluRzRvcFVuMXBZT3F3S0hVUzlxSnZNSjZleGhkY0tJUVpmd1ZVM3EtMDZOQmdGOHUzaUN0NmRxRG10QjI5VE9qRE5Fam51STVlS0pJMV9EOTN0QV9MeThNODFNdE93?oc=5) |
| Stocktwits | LLY, ABBV Stocks Hit All-Time High | 2026-10-30 11:51 | [Source Link](https://news.google.com/rss/articles/CBMi3gFBVV95cUxQenYwR3ptWXFyQmYxRVpfUzh0aGNqZmdraVRsQ2M2NHQzTmFCaUd3NVBqb0hUeWhEdVNSY2pfaUdIQmFsY09TUmFmcDBPS2g4WVdtSGpqRUhpaGxHWVRVTjB4cGJET3VsVTVsUy1jT1ctX2VPQmF1dTBDaUpEdWlTOTg3cF9kLWNncWdPZEd3XzZNN0pPRVRfdTZUaklXcDV4dndSTUFaRTU5ckxoUHFhaVdVVTdWTmZDTUsxM2RMb3REbFl3RkhNRW52SGlyTTJ5ZzJXVVlXUnNiaWNpMHc?oc=5) |
| Yahoo Finance | What AbbVie (ABBV) Said on Its Q3 Earnings Call | 2026-10-30 11:51 | [Source Link](https://news.google.com/rss/articles/CBMikwFBVV95cUxPVVAwVnlvTTlWcUc3NXc2SElFcUVJX0RfYTEtTno5eXViMEhBRWJSSTduU2hpMGt3V1BiMjQ0THl5TUFLQTRuLVZ3QWl2UWt2TW1GVXY1RXlpOWNDbWhxekphdUg1YXBuQlAyQlhGX0ZwazNrV0Nnb1VuZERqcHBGclhXUS1BMTRHb3A2b1JSYm03MU0?oc=5) |
| Crain's Chicago Business | AbbVie’s earnings double as drugmaker eyes a move into obesity treatments | 2026-10-30 11:51 | [Source Link](https://news.google.com/rss/articles/CBMijwFBVV95cUxOVVZET3hTWi1ZYjRXOHc0dmNhaEtmbEwtRzkydTRySzl4UXlIN3JvZXlZcm5ySGVHWDJfLS1SNUhDTnlLVkhaVUVvbkZJWTBRMlJzMnJBTDdDVXV6SWVhN3dSSmwtZzMtdWY4clMtSVY3VmNSZFRpMjRqQlpkeGRyS1FuNTVPR1g3MGo0RmpIUQ?oc=5) |
| Reuters | AbbVie lifts annual profit forecast as immunology drugs continue to fuel growth | 2026-10-30 11:51 | [Source Link](https://news.google.com/rss/articles/CBMiuwFBVV95cUxPNjJPY3ZXYmJiVGxxQ3E4ZERuMXJwM2pnNEZRZmE2SVY1UVQ5bjg1Z25OTVV0VU1xc21LUkpmZWNQUmlBbU9keW9SV1M5ODRpRnVCQ25MU1ZPV1RzN2ptQW5oVHh5SldjZm1aSEtRY29MR3k1dVVBLXhFbVF0ZWNqUWlMZ1ZhdW5DM2lvTmVpdFJ0NEZncGV0Vk4wVV9IRDdrOHpOc1pCcGF0S2dkc0JFekppdzVXWjB0TUtV?oc=5) |
| Yahoo Finance | AbbVie beats estimates but stock dips | 2026-10-30 11:51 | [Source Link](https://news.google.com/rss/articles/CBMimgFBVV95cUxOTHpBcmRsWVdFWXJmanVxcTJMb2o0dEZRTW5xYUZ0WXRZOFJNb1Vxa21QSDdBV21WRkVsaUVjaWEtTHdJaFlwcmsxMDJnZFRnQ1lqdVpCUDVYck44RWxvZng2cHl2cTRpWFlMXzVhRUJySlRZWHNlSm54aDJJVGl3bHNTdG13SUowZlJSMnliemFBNHRLckItN2Rn?oc=5) |
| WSJ | AbbVie Revenue Rises on Strength in Immunology, Neuroscience | 2026-10-30 11:51 | [Source Link](https://news.google.com/rss/articles/CBMiqgFBVV95cUxOVHBFalVsU1c5dGxfMElsYjdWUkFPWXVTTDdJbDF6Vm1WekowQWZJVXpHS3MxYzExOXBvT3JfMlBsOVBodWVPdE9mVDAwQ0RRcFNlM3BNUXRKamotcG5wZVpPQXY2c243S25naUlyS3ZTd1lEY2QzSmpjUjJrcjRmazRBRmhnNjRrOTNrTnJrWGVYVUtrNEYtMUZ3OVFSc19vbHJENEpxMWtRUQ?oc=5) |
| AbbVie News Center | AbbVie Reports Third-Quarter 2026 Financial Results | 2026-10-30 11:51 | [Source Link](https://news.google.com/rss/articles/CBMijwFBVV95cUxQbkJ1dThsWktBNWNpVjg0cXRkamIyVVBBZHdXaDRHdVFzUHJzUnBqQ1l6TV8xc3piTk1mNzJ2WTY0UklQLTUyQXhpNVZMSEZ5UWl0TGlMSlVLRThGbENxSjAzX0dzV2xjMUE5Nlc3UU5yb1c0TkNodVpvamR4N2lQWjlhaXNKX3lhZkllWnVwaw?oc=5) |
| Starbucks Investor Relations | Starbucks Reports Q4 and Full Fiscal Year 2026 Results | 2026-10-29 20:12 | [Source Link](https://news.google.com/rss/articles/CBMi1wFBVV95cUxOdUlhMDJ2eXQ0cHlKNC1neEVaVVlxSEwwOHZjZHFhN3pPX3RfZ3VlY0lCQWI2RTJXZVEwSks0VHlsLU5GOUg1TXVLQURhcUR0UVB3bExTRVYzTXZTQzZPRHhfeWRiSmtPMDRneVFKVnpFbFZjNTNfVUU0bVFTYjNtMDI3dUVfQlJqVG1iMjVzOGRRRzBvRUt1b1EwZ214Q1pQUlFfZUVfczgtN0RLMU5xd0Nkem16TkV5Y2JhVjdEbGJBclFTdTNZbjZRSFlyblgtMWZJb3FKUQ?oc=5) |
| Yahoo Finance | Eli Lilly stock jumps as drugmaker raises outlook on booming sales of diabetes and obesity treatments | 2026-10-29 10:45 | [Source Link](https://news.google.com/rss/articles/CBMivAFBVV95cUxPeGtWdk5nckZlTlVWNXQzNFczd3dnbVpKaTE1Sm9pWGt4bHpvYzFMbUg2VzJZWXJVbHV0TVJLLXhUUUxrVXFzQ0prTjJmY0t3c0dvV1dSS1JOOV9KbkpCSDN1YTNfTHZUejdiQk5pVzZtSmVTS3hpc21sVEhneFJkSFFoTjJKb09ieDc0aUhHYUd1d3F4a2t2aThGSHNFV2lKUzduRF9JcWxwZUdwZGdrd3dyYjJ6UGdKVHVRZQ?oc=5) |
| Reuters | Lilly's obesity drug strength fuels record rally, Wall Street optimism | 2026-10-29 10:45 | [Source Link](https://news.google.com/rss/articles/CBMiwgFBVV95cUxNU0YzV3hGTVUxblYxbUdSYTdJN1hLV254S0JXd3BHVHc4OEVQeTZDaG1oUkJVdDkwdmYtYXpUVWNER2ZJNndsNHVDQWdOS2FXM1RZVnpxTEJJU1JTazM0VmxvYVd4V2lQcTVjQXpLY0NXdDl1SndneUo3bzlNRmlUcVNlSXludFB5bURpbk5OdjI2T3RvdHlrekp0Sk56QzFkS0JfZmdCTktwb3pjUDN3YUU4emxGVS1aM2lrYXJ3V0Rkdw?oc=5) |
| Fierce Pharma | Lilly breaks down Medicare Bridge boon as GLP-1 sales drive another guidance lift | 2026-10-29 10:45 | [Source Link](https://news.google.com/rss/articles/CBMitAFBVV95cUxPcTdNdHc1QkE5SjdITmYxcXM2aDlNZzJHdEt2UFNvRHpJOE9vY21DQXdocEhGMncwcXFiUGExakVVZlpwUjcyVUlRUlVQcEhld2pDbjctSmp1a1FvVkpDdUotNnRHU1BZYzNtWkhxQnlxZHluTXMybWp6RUpHZDhCQVJpOGJlQXJHY0tKRUUwbUh2eWVJQkM2Sl9mUkZsQUFRRC01czJNRlFlUHZTR21faGgtSE4?oc=5) |
| Yahoo Finance | Lilly: Q3 Earnings Snapshot | 2026-10-29 10:45 | [Source Link](https://news.google.com/rss/articles/CBMilgFBVV95cUxQek5oTkhvSm9BMUx5aW5hYWNyR0pzUHZOTnU2MmRkQTgxMHF3RGdHcTZhYm5weDhhNG4xZk1Td1c5Y3ZqQzBTWnZRc21CWmI2bkFJZjF2MmhvcGRHMUd6SFhqUmZVcnlwSHRvYzJsZXY0XzBWNXZmaHduMDhvcHNPMkE4RGpYM1N2eE5GZjdCSWJsMTNEUlE?oc=5) |
| Reuters | Eli Lilly lifts revenue outlook on weight-loss drug sales, trims profit view on deal charges | 2026-10-29 10:45 | [Source Link](https://news.google.com/rss/articles/CBMi4wFBVV95cUxOOFBMR0czdDM3ak5TQVJZYmZ5cENsNkZQaGRSRlFocDQ4dThYVmUyTFV6Z0x5VXVyX3BRTmF3R1lta0lRVGdSN0NDWmJMZzUwRUIwTnN4RFlpLVNhQi1oZVl0WER0M3NOcnFQR0FQa3hBck0yY1Y0T0dkOS1wZm1iaUQ4YjNsZzY0NzFoU0w2cGh3bmQzekRUanFTa29GdDF6RFdYQ3lqV200Y1NiaENLQWdFUEVValozTzMwYjFWS1UyTExLV01NZkxjQm9EcWFDNUNEYWk4XzhDekxCU0R4M0pjYw?oc=5) |

---
*Canonical Source: https://www.newsylist.com/trend/2026-10-29/lilly-reports-third-quarter-2026-financial-results-raises-full-year-guidance*
*Synthesized by Newsylist Open Intelligence Engine under E-E-A-T journalistic standards.*